Patent application number | Description | Published |
20120104797 | FRONT MODULE FOR A MOTOR VEHICLE - A front module for a motor vehicle includes two longitudinal members arranged one on either side, a bumper sitting in front of the two longitudinal members and connected to front ends of the longitudinal members with the interconnection of a respective deformation element, and a radiator frame arranged between the longitudinal members and supporting the cooling assembly. In a collision, the bumper, after the deformation of the deformation element, comes to bear against the radiator frame, wherein the radiator frame can then be displaced for a limited distance to the rear in the direction of the passenger compartment. After displacement or deformation of the radiator frame, the bumper ( | 05-03-2012 |
20120181818 | FRONT-END STRUCTURE OF A MOTOR VEHICLE - Forward structure of a motor vehicle includes a frame structure, a bumper beam disposed forward of and connected to the frame structure, and a radiator frame disposed forward of the frame structure and behind the bumper beam. First and second swing arms are connected to the radiator frame at respective first and second forward pivot axes and are connected to the frame structure at respective first and second rear pivot axes. The four pivot axes are substantially parallel to one another and substantially transverse to the vehicle, such that a frontal impact urging the bumper beam rearward against the radiator frame causes the radiator frame to pivot about the swing arms. Forward-most portions of the frame structure, immediately adjacent to the bumper beam, may take the form of deformation elements or crush cans that are designed to yield in a manner to absorb crash energy. | 07-19-2012 |
20130270869 | BODYWORK ARRANGEMENT FOR A FRONT END AND A PASSENGER COMPARTMENT OF A VEHICLE - Bodywork arrangement comprising longitudinal members and cross-members that are connected at node points to other lateral structural elements to form part of a passenger compartment and part of a vehicle front end. Longitudinal members are provided at the lower side of the passenger compartment. Front-end longitudinal members are arranged on the vehicle front end. A front region of the passenger compartment has a floor cross-member, a splashboard cross-member, an armature cross-member and laterally arranged A-column elements. The floor cross-member together with the splashboard cross-member and two lateral structural elements form a lower trapezoidal structure. The splashboard cross-member together with the armature cross-member ( | 10-17-2013 |
Patent application number | Description | Published |
20100093679 | DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY - A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with deficient endogenous levels of estrogen in women, and as a second active ingredient 6β,7β;15β;16β-dimethylene-3-oxo-17α-preg-4-ene-21,17-carbolactone (drospirenone, DRSP) in sufficient amounts to protect the endometrium from the adverse effects of estrogen is useful for, amongst others, treating peri-menopausal, menopausal and post-menopausal women. This composition may be used for hormone replacement therapy and may be administered as a multi-phased pharmaceutical preparation. This combination therapy may comprise continuous, sequential or interrupted administration, or combinations thereof, of DRSP and estrogen, each optionally in micronized form. | 04-15-2010 |
20120220556 | DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY - A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with deficient endogenous levels of estrogen in women, and as a second active ingredient 6β,7β;15β;16β-dimethylene-3-oxo-17α-preg-4-ene-21,17-carbolactone (drospirenone, DRSP) in sufficient amounts to protect the endometrium from the adverse effects of estrogen is useful for, amongst others, treating peri-menopausal, menopausal and post-menopausal women. This composition may be used for hormone replacement therapy and may be administered as a multi-phased pharmaceutical preparation. This combination therapy may comprise continuous, sequential or interrupted administration, or combinations thereof, of DRSP and estrogen, each optionally in micronized form. | 08-30-2012 |